Recombinant biologic products versus nutraceuticals from plants - a regulatory choice?

Drake, Pascal M W

Recombinant biologic products versus nutraceuticals from plants - a regulatory choice? [electronic resource] - British journal of clinical pharmacology 01 2017 - 82-87 p. digital

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't

1365-2125

10.1111/bcp.13041 doi


Antibodies, Monoclonal
Biological Products--standards
Biotechnology--legislation & jurisprudence
Dietary Supplements--standards
Drug Labeling
Legislation, Drug
Molecular Farming--legislation & jurisprudence
Plants, Genetically Modified
Recombinant Proteins--biosynthesis